Acute necrotizing encephalopathy
| Acute necrotizing encephalopathy | |
|---|---|
| Synonyms | ANE |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Seizures, altered mental status, coma |
| Complications | Neurological deficits, death |
| Onset | Rapid |
| Duration | Variable |
| Types | |
| Causes | Viral infection, genetic predisposition |
| Risks | Influenza, human herpesvirus 6, parainfluenza, rubella |
| Diagnosis | MRI, CT scan, lumbar puncture |
| Differential diagnosis | Encephalitis, Reye's syndrome, metabolic disorders |
| Prevention | |
| Treatment | Supportive care, corticosteroids, immunoglobulins |
| Medication | |
| Prognosis | Variable, often poor |
| Frequency | Rare |
| Deaths | |
Acute Necrotizing Encephalopathy
Acute Necrotizing Encephalopathy (ANE) is a rare and severe neurological condition characterized by rapid onset of fever, seizures, and altered mental status, often following a viral infection. It is most commonly seen in children and can lead to significant morbidity and mortality.
Etiology[edit]
ANE is often associated with viral infections, particularly influenza A, influenza B, and human herpesvirus 6. The exact pathophysiological mechanism is not fully understood, but it is believed to involve an exaggerated immune response leading to widespread inflammation and necrosis in the brain.
Clinical Presentation[edit]
Patients with ANE typically present with:
- High fever
- Seizures
- Altered consciousness
- Rapid progression to coma
Neurological symptoms often develop rapidly after the onset of fever, and the condition can progress to coma within a few days.
Diagnosis[edit]
The diagnosis of ANE is primarily based on clinical presentation and imaging studies. Magnetic Resonance Imaging (MRI) is the preferred modality and typically shows symmetric lesions in the thalami, brainstem, and other regions of the brain.
Treatment[edit]
There is no specific treatment for ANE, and management is primarily supportive. High-dose corticosteroids and intravenous immunoglobulin (IVIG) have been used in some cases with varying success. Early recognition and supportive care in an intensive care setting are crucial.
Prognosis[edit]
The prognosis of ANE is generally poor, with high rates of mortality and significant neurological sequelae in survivors. Early intervention and aggressive supportive care may improve outcomes in some cases.
Genetic Factors[edit]
Some cases of ANE have been linked to genetic mutations, particularly in the RANBP2 gene, which may predispose individuals to the condition. This suggests a possible genetic susceptibility in some patients.
Epidemiology[edit]
ANE is a rare condition, with most cases reported in East Asia, particularly Japan and Taiwan. However, cases have been reported worldwide.
See Also[edit]
NIH genetic and rare disease info[edit]
Acute necrotizing encephalopathy is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Acute necrotizing encephalopathy
|
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian